Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8283115
SERIAL NO

12143705

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds and assays for the identification and validation of compounds for use in the treatment of muscular dystrophy (MD), or a form thereof, in which said compounds increase the post-transcriptional expression of a target gene (i.e., mIGF1, ITGA7, or UTRN).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MIDCAP FINANCIAL TRUST AS AGENT7255 WOODMONT AVE SUITE 200 BETHESDA MD 20814

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Friesen, Westley J Huntingdon Valley, US 5 9
Naryshkin, Nikolai East Brunswick, US 26 242
Patel, Meenal Fairless Hills, US 7 71
Romfo, Charles Easton, US 7 76
Tomizawa, Yuki Edison, US 6 16
Welch, Ellen Califon, US 37 313
Zhuo, Jin Belle Mead, US 3 43

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation